Ultrasound-guided Transgluteal Sciatic Nerve Hydrodissection for the Treatment of Sciatica in the Emergency Department

NCT07588126 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2026-05-14

No results posted yet for this study

Summary

The goal of this observational study is to see whether it would be feasible to treat patients who come to the emergency department with pain related to sciatica using an ultrasound guided injection of dextrose in water solution ("sugar water") into the tissue that surrounds the sciatic nerve in the gluteal region. THe study will looks at a few things:

* Is the treatment feasible within the setting of the emergency department
* Is the treatment safe in the short term (up to 72 hours after the injection)
* Is the treatment good for lowering patients' pain from sciatica in the short term (immediate and up to 72 hours' follow up)
* How does the treatment compare to current standard medicines given to patients for sciatica in the emergency department in terms of lowering pain

Patients who came to the emergency department and had the injection as part of their care for sciatica will answer some questions about their symptoms during a phone call follow up 72 hours after leaving the emergency department.

Conditions

  • Sciatica Acute
  • Sciatica Pain

Interventions

PROCEDURE

Ultrasound guided transgluteal sciatic nerve hydrodissection

Injection of dextrose in water solution (D5W) under ultrasound guidance into the tissue plane that encloses the sciatic nerve between its two neighboring muscles.

Sponsors & Collaborators

Principal Investigators

  • Gabriel Rose · Kaiser Permanente

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2025-02-21
Completion
2025-02-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07588126 on ClinicalTrials.gov